Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

COVID-19 RESEARCH

COVID-19 RESEARCH

ARENSIA has contributed to numerous research projects with innovative compounds enrolling more than 1,500 COVID-19 patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

ARENSIA IS EXPANDING IN ROMANIA!

HOME · NEWS · ARENSIA IS EXPANDING IN ROMANIA!

We are pleased to announce ARENSIA´s expansion to Cluj, the second largest city in Romania.
Eleven years since the start-up of ARENSIA´s operations in Bucharest, we are excited to grow our presence in Romania and offer patients in Cluj and surroundings access to innovative therapies early on in the drug development process. 

ARENSIA is collaborating with leading medical institutions in Cluj, which are serving the entire Transylvania region (population 7,5 Mio), and are equipped with the latest generation diagnostics technologies.

ARENSIA´s research facilities in Cluj will serve early phase clinical trials in oncology, haemato-oncology, as well as multi-therapeutic indications such as Rheumatology, Cardiology (incl. Interventional Cardiology), Pulmonology, Neurology, Psychiatry, Diabetes/Nutrition/Metabolic, Ophthalmology, Endocrinology, Gastroenterology, Dermatology, Nephrology, Neurology, Obstetrics-Gynaecology, and Orthopaedics-Traumatology.

ARENSIA team at this location is composed of research professionals (physicians, nurses, technicians, project coordinators, etc.) with vast experience in handling most complex exploratory protocols and innovative therapies & combinations related to first-in-man / first-in-patients study designs. 

Please feel free to contact us at any stage to learn more about our newest capabilities in Cluj.

31.08.2022
VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse